Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring.
Xing D, Kollman C, Beck RW, Tamborlane WV, Laffel L, Buckingham BA, Wilson DM, Weinzimer S, Fiallo-Scharer R, Ruedy KJ; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Xing D, et al. Diabetes Technol Ther. 2011 Mar;13(3):351-8. doi: 10.1089/dia.2010.0156. Epub 2011 Feb 7. Diabetes Technol Ther. 2011. PMID: 21299401 Free PMC article. Clinical Trial.
Factors predictive of severe hypoglycemia in type 1 diabetes: analysis from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized control trial dataset.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Fiallo-Scharer R, Cheng J, Beck RW, Buckingham BA, Chase HP, Kollman C, Laffel L, Lawrence JM, Mauras N, Tamborlane WV, Wilson DM, Wolpert H. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, et al. Diabetes Care. 2011 Mar;34(3):586-90. doi: 10.2337/dc10-1111. Epub 2011 Jan 25. Diabetes Care. 2011. PMID: 21266651 Free PMC article. Clinical Trial.
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).
Stroup TS, McEvoy JP, Ring KD, Hamer RH, LaVange LM, Swartz MS, Rosenheck RA, Perkins DO, Nussbaum AM, Lieberman JA; Schizophrenia Trials Network. Stroup TS, et al. Among authors: lavange lm. Am J Psychiatry. 2011 Sep;168(9):947-56. doi: 10.1176/appi.ajp.2011.10111609. Epub 2011 Jul 18. Am J Psychiatry. 2011. PMID: 21768610 Free PMC article. Clinical Trial.
Health utilities for children and adults with type 1 diabetes.
Lee JM, Rhee K, O'grady MJ, Basu A, Winn A, John P, Meltzer DO, Kollman C, Laffel LM, Lawrence JM, Tamborlane WV, Wysocki T, Xing D, Huang ES; JDRF Continuous Glucose Monitoring Study Group. Lee JM, et al. Med Care. 2011 Oct;49(10):924-31. doi: 10.1097/MLR.0b013e318216592c. Med Care. 2011. PMID: 21544001 Free PMC article.
Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group; Beck RW, Buckingham B, Miller K, Wolpert H, Xing D, Block JM, Chase HP, Hirsch I, Kollman C, Laffel L, Lawrence JM, Milaszewski K, Ruedy KJ, Tamborlane WV. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, et al. Diabetes Care. 2009 Nov;32(11):1947-53. doi: 10.2337/dc09-0889. Epub 2009 Aug 12. Diabetes Care. 2009. PMID: 19675206 Free PMC article. Clinical Trial.
Sertraline versus imipramine to prevent relapse in chronic depression.
Koran LM, Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, Klein D, Kocsis JH, Schatzberg AF, Thase ME, Rush AJ, Hirschfeld RM, LaVange LM, Keller MB. Koran LM, et al. Among authors: lavange lm. J Affect Disord. 2001 Jun;65(1):27-36. doi: 10.1016/s0165-0327(00)00272-x. J Affect Disord. 2001. PMID: 11426506 Clinical Trial.
97 results